To Pace or not to Pace for Neurally Mediated Syncope: Do We Know the Answer? A Positive View
Single chamber VVI mode pacing proved to be ineffective in vasovagal syncope treatment , while several nonrandomized studies [2–4] showed a significant decrease in recurrence in patients who underwent dual chamber pacing. In the last few years, three randomized, noncontrolled studies have shown the efficacy of dual-chamber pacemaker implantation in reducing recurrence in patients with recurrent neuromediated syncope. The VPS study  demonstrated the effectiveness of rate-drop response pacemakers in patients affected by neurally mediated syncope who gave a positive response in the tilting test, presenting a varying cardoinhibitory component. The VASIS study , on the other hand, showed the effectiveness of a DDI-mode pacemaker with hysteresis in patients with neurally mediated syncope and positive tilting test with a marked cardoinhibitory component. Finally, the SYDIT trial  reported the superiority of pacemaker implantation over drug treatment with ß-blockers.
KeywordsPacemaker Implantation Vasovagal Syncope Syncopic Recurrence Active Pace Implant Loop Recorder
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Benditt DG, Petersen M, Lurie KG et al (1995) Cardiac pacing for the prevention of recurrent vasovagal syncope. Ann Intern Med 122:204–209PubMedGoogle Scholar
Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP et al (1994) Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 71:274–281PubMedCrossRefGoogle Scholar
Benditt DG, Sutton R, Gammage M, Fetter J, Markowitz T and the Rate-Drop Response Investigators (1997) Clinical experience with Thera DR rate drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. Pacing Clin Electrophysiol 20:832–839PubMedCrossRefGoogle Scholar
Sheldon R, Koshman ML, Wilson W et al (1998) Effect of dual chamber pacing with automatic rate-drop sensing on recurrent neutrally mediated syncope. Am J Cardiol 81:158–162PubMedCrossRefGoogle Scholar
Connolly SJ, Sheldon R, Roberts RS, Gent M (1999) The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16–20CrossRefGoogle Scholar
Sutton R, Brignole M, Menozzi C et al on behalf of the Vasovagal Syncope International Study (VASIS) Investigators (2000) Dual-chamber pacing is efficacious in treatment of neurally-mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicentre randomized study. Circulation 102:294–299PubMedCrossRefGoogle Scholar
Ammirati F, Colivicchi F, Santini M et al (2001) Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. Circulation 104:52–57PubMedCrossRefGoogle Scholar
Connolly SJ, Sheldon R, Thorpe KE et al (2003) Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope (VPS II): a randomized trial. JAMA 289:2224–2229PubMedCrossRefGoogle Scholar
Giada F, Raviele A, Menozzi C et al (2003) The Vasovagal Syncope and Pacing Trial (Synpace). A randomized, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent vasovagal syncope. Pacing Clin ElectrophysiolGoogle Scholar
Deharo JC, Peyre JP, Chalvidian T et al (2000) Continuous monitoring of an endocar-dial index of myocardial contractility during head-up tilt test. Am Heart J 139:1022–1030PubMedCrossRefGoogle Scholar
Kurbaan AS, Erikson M, Petersen MEV et al (2000) Respiratory changes in vasovagal syncope. J Cardiovasc Electrophysiol 11:607–611PubMedCrossRefGoogle Scholar
© Springer-Verlag Italia 2004